Literature DB >> 10383553

Target concentration intervention: beyond Y2K.

N H Holford1.   

Abstract

Target concentration intervention (TCI) is proposed as an alternative conceptual strategy to therapeutic drug monitoring (TDM). It is argued that the idea of a therapeutic range has limited the interpretation of measured drug concentrations and diminished the anticipated clinical benefit to patients by use of an oversimplified pharmacodynamic model. TCI on the other hand embraces pharmacokinetic and pharmacodynamic concepts and uses the idea of a target effect and associated target concentration to make rational individual dose decisions.

Entities:  

Mesh:

Year:  1999        PMID: 10383553      PMCID: PMC2014870          DOI: 10.1046/j.1365-2125.1999.00971.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Holford NHG and Sheiner LB "Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models", Clin Pharmacokin 6:429-453 (1981)-The Backstory.

Authors:  Nick Holford
Journal:  AAPS J       Date:  2011-10-18       Impact factor: 4.009

3.  The randomized concentration-controlled trial: an evaluation of its sample size efficiency.

Authors:  L P Sanathanan; C C Peck
Journal:  Control Clin Trials       Date:  1991-12

Review 4.  Target concentration strategy for cyclosporin monitoring.

Authors:  R G Morris
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

5.  Comparative efficiencies of randomized concentration- and dose-controlled clinical trials.

Authors:  L Endrenyi; J Zha
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

6.  The importance of modeling interoccasion variability in population pharmacokinetic analyses.

Authors:  M O Karlsson; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1993-12

Review 7.  The therapeutic monitoring of antimicrobial agents.

Authors:  E J Begg; M L Barclay; C J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 8.  Comparison of drug dosing methods.

Authors:  M E Burton; M R Vasko; D C Brater
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

9.  Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial.

Authors:  N Holford; Y Hashimoto; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

10.  Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial.

Authors:  N Holford; P Black; R Couch; J Kennedy; R Briant
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

View more
  21 in total

1.  Clinical pharmacology: principles and practice of drug therapy in medical education.

Authors:  Brian Whiting; Nicholas H G Holford; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimens.

Authors:  Jürgen B Bulitta; Martina Kinzig; Verena Jakob; Ulrike Holzgrabe; Fritz Sörgel; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

3.  Limited predictability of amikacin clearance in extreme premature neonates at birth.

Authors:  Karel Allegaert; Brian J Anderson; Veerle Cossey; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Authors:  João A Abrantes; Siv Jönsson; Mats O Karlsson; Elisabet I Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

5.  Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach.

Authors:  Guillaume Claisse; Paul J Zufferey; Jane C Trone; Nicolas Maillard; Xavier Delavenne; Silvy Laporte; Edouard Ollier
Journal:  Br J Clin Pharmacol       Date:  2019-04-07       Impact factor: 4.335

Review 6.  Benchmarking therapeutic drug monitoring software: a review of available computer tools.

Authors:  Aline Fuchs; Chantal Csajka; Yann Thoma; Thierry Buclin; Nicolas Widmer
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

Review 7.  Is there a role for therapeutic drug monitoring of new anticonvulsants?

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

8.  Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Authors:  Stefanie Hennig; Ross Norris; Carl M J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

9.  Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.

Authors:  Karel Allegaert; Brian J Anderson; Gunnar Naulaers; Jan de Hoon; Rene Verbesselt; Anne Debeer; Hugo Devlieger; Dick Tibboel
Journal:  Eur J Clin Pharmacol       Date:  2004-04-08       Impact factor: 2.953

10.  Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure.

Authors:  Satofumi Iida; Haruki Kinoshita; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.